Resources with keywords: testing
A Year into the COVID Pandemic (Document)
This document provides the questions that should be addressed in order to determine what biosafety mitigation strategies need to be used when handling and processing unfixed human blood during the pandemic. The issues addressed should be included in the IBC protocol narrative. The final determination of handling requirements must be made in consultation with the Biological Safety Division and the Institutional Biosafety Committee (IBC).
Kalish, H, Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States. Sci Transl Med. 2021:13. DOI: 10.1126/scitranslmed.abh38
Kalish H, et al.
The authors measured antibody prevalence in study participants who had not previously been diagnosed with a SARS-CoV-2 infection during the first wave of the COVID-19 pandemic
